Company intelligence / Profile preview

Valence Investments SPV VI

Ownership: Private
Development stage: Other

Overview

Valence Investments SPV VI is an investment entity, not an operating biotech or pharma company, and does not have its own clinical, research, or product development activities. It serves as an investment vehicle to hold equity in life science/biotech companies such as CalciMedica.

Industry: Investors

Beyond the preview

Go deeper on Valence Investments SPV VI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valence Investments SPV VI.

Explore the full profile